Published in Am J Cardiol on February 15, 2005
Updates in cardiac amyloidosis: a review. J Am Heart Assoc (2012) 2.21
Strain imaging in echocardiography: methods and clinical applications. Int J Cardiovasc Imaging (2009) 1.37
Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS). Circ Heart Fail (2010) 1.07
Use of tissue Doppler imaging to identify and manage systemic diseases. Clin Res Cardiol (2007) 0.87
Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography. Int J Cardiovasc Imaging (2016) 0.75
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol (2005) 5.64
Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern Med (2014) 4.78
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med (2004) 4.05
The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med (2015) 3.36
Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation (2011) 2.94
A primer of amyloid nomenclature. Amyloid (2007) 2.70
Diagnostic value of peripheral fractional flow reserve in isolated iliac artery stenosis: a comparison with the post-exercise ankle-brachial index. J Endovasc Ther (2014) 2.63
Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med (2005) 2.33
Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid (2005) 2.14
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging (2012) 2.03
Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging (2010) 1.93
Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid (2010) 1.91
Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging (2014) 1.91
Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation (2003) 1.71
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clin Lymphoma (2003) 1.69
Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest (2003) 1.68
Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol (2003) 1.67
Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation. Circ J (2014) 1.51
Low cardiac output stimulates vasopressin release in patients with stage d heart failure. Circ J (2014) 1.50
Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction – ALPS-AMI study. Circ J (2014) 1.48
Advantage of Pulsatility in Left Ventricular Reverse Remodeling and Aortic Insufficiency Prevention During Left Ventricular Assist Device Treatment. Circ J (2015) 1.46
Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis (2010) 1.46
Valve repair improves central sleep apnea in heart failure patients with valvular heart diseases. Circ J (2009) 1.45
Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students. Circ J (2010) 1.44
Myasthenia gravis with anti-MuSK antibody, showing progressive muscular atrophy without blepharoptosis. Intern Med (2005) 1.42
Prevalence of vitreous hemorrhage following coronary revascularization in patients with diabetic retinopathy. Circ J (2010) 1.40
Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device. Circ J (2014) 1.40
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood (2004) 1.38
Comparison of Inflammatory Biomarkers in Outpatients With Prior Myocardial Infarction. Int Heart J (2016) 1.38
Presence of diastolic dysfunction in patients with peripheral artery disease. Angiology (2013) 1.37
Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene. J Clin Neurosci (2008) 1.30
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J (2009) 1.20
Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels (2010) 1.16
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Transplantation (2015) 1.13
Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest (2003) 1.10
Successful treatment of primary cardiac angiosarcoma with docetaxel and radiotherapy. Angiology (2008) 1.10
Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation (2005) 1.10
Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol (2009) 1.09
"Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanisms. JACC Heart Fail (2014) 1.09
Cardiac amyloidosis. Circulation (2012) 1.08
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J (2012) 1.07
Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol (2013) 1.06
Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. Mov Disord (2006) 1.06
Adult or late-onset triple A syndrome: case report and literature review. J Neurol Sci (2010) 1.05
Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol (2011) 1.04
Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett (2004) 1.03
Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr (2004) 1.01
Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide. Circulation (2012) 1.01
Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology (2006) 1.00
Plaque morphology at coronary sites with focal spasm in variant angina: study using intravascular ultrasound. Circ J (2003) 1.00
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation (2014) 1.00
Negative pressure wound therapy for left ventricular assist device-related mediastinitis: two case reports. J Artif Organs (2011) 0.99
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid (2013) 0.98
Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med (2005) 0.97
Prolonged biventricular assist device support as a bridge to heart transplantation. J Artif Organs (2011) 0.96
Parasympathetic reinnervation accompanied by improved post-exercise heart rate recovery and quality of life in heart transplant recipients. Int Heart J (2015) 0.95
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid (2005) 0.93
Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol (2002) 0.92
Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Neuropathology (2007) 0.92
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol (2013) 0.91
Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J (2012) 0.91
Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis. J Mol Cell Cardiol (2005) 0.91
The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clin Proc (2004) 0.91
Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation (2002) 0.91
Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats. J Cardiovasc Pharmacol (2005) 0.89
Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats. Cardiovasc Res (2003) 0.89
Neutralization of CXCL10 accelerates liver regeneration in carbon tetrachloride-induced acute liver injury. Med Mol Morphol (2007) 0.89
Status 2 patients had poor prognosis without mechanical circulatory support. Circ J (2014) 0.89
Use of DuraHeart® support for more than 1 year as the first successful bridge to heart transplantation in Japan. J Artif Organs (2010) 0.89
Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J (2014) 0.88
Early cardiac involvement in senile systemic amyloidosis: a case report. Amyloid (2008) 0.88
Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis. Amyloid (2015) 0.88
Pneumatosis cystoides intestinalis in neuropsychiatric systemic lupus erythematosus with diabetes mellitus: case report and literature review. Mod Rheumatol (2011) 0.88
Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy. Eur Heart J Cardiovasc Imaging (2011) 0.87
Relationship of plasma brain-type natriuretic peptide levels to left ventricular longitudinal function in patients with congestive heart failure assessed by strain Doppler imaging. Int J Cardiol (2007) 0.87
Crucial role of hyaluronan in neointimal formation after vascular injury. PLoS One (2013) 0.87
Biventricular failure with low pulmonary vascular resistance was managed by left ventricular assist device alone without right-sided mechanical support. J Artif Organs (2015) 0.87
Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations. Intern Med (2005) 0.86
Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis. Med Mol Morphol (2007) 0.86
Adult onset X-linked chronic granulomatous disease in a woman patient caused by a de novo mutation in paternal-origin CYBB gene and skewed inactivation of normal maternal X chromosome. Intern Med (2008) 0.86
Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support. J Artif Organs (2015) 0.85
Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid (2005) 0.85
Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid (2005) 0.85
Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. Amyloid (2002) 0.85
Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol (2005) 0.85
Calciphylaxis as a Catastrophic Complication in a Patient with POEMS Syndrome. Case Rep Neurol (2009) 0.85
Successful bridge to recovery with VAD implantation for anthracycline-induced cardiomyopathy. J Artif Organs (2011) 0.85
Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma. J Clin Neurosci (2006) 0.85
Risk factors for hospital-acquired bacteremia. Intern Med (2005) 0.84
Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Hepatol Res (2005) 0.84
The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE. J Clin Hypertens (Greenwich) (2012) 0.84
Severe hypercalcaemia mimicking acute myocardial infarction. Clin Med (2009) 0.84
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol (2002) 0.84
Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Am Heart J (2002) 0.83
Successful treatment of mediastinitis after ventricular assist device implantation with rerouting of the outflow vascular prosthesis. J Artif Organs (2011) 0.83